Benitec Biopharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results and a Year-over-year Decrease in Q3 Revenue Results.
Benitec Biopharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results and a Year-over-year Decrease in Q3 Revenue Results.
Benitec Biopharma公佈的第三季度GAAP每股收益低於預期，第三季度收入業績同比下降後，股價走低。
Benitec Biopharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results and a Year-over-year Decrease in Q3 Revenue Results.
Benitec Biopharma公佈的第三季度GAAP每股收益低於預期，第三季度收入業績同比下降後，股價走低。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。